Literature DB >> 12839109

Ocular allergy: implications for the clinical immunologist.

C H Katelaris1.   

Abstract

BACKGROUND: Allergic diseases of the eye are the most common conditions affecting the external ocular adnexa. The most common forms are primarily IgE-mediated and share features in common with other atopic conditions. Mast cell activation and release of mediators, particularly histamine, are central to the pathogenesis of seasonal and perennial allergic conjunctivitis. These conditions are self-limited without the occurrence of ocular surface damage. In contrast, vernal keratoconjunctivitis and atopic keratoconjunctivitis are complex diseases, involving both early- and late-phase allergic responses. They are characterized by severe chronic immune inflammation with T cell infiltration in the conjunctiva and may be sight-threatening.
OBJECTIVES: To provide a brief overview of the ocular allergic conditions and summarize the current knowledge of immunopathogenetic mechanisms involved in initiating and driving these conditions. DATA SOURCES: English-language articles were sought from a MEDLINE search from 1995. This yielded a number of scientific and review papers exploring recent advances in the understanding of the pathogenesis of the ocular allergic conditions.
CONCLUSIONS: Recent advances in knowledge about the pathogenetic mechanisms involved in ocular allergy have led to a better understanding of treatment options and to the development of new treatment modalities, resulting in improved control of symptoms for patients.

Entities:  

Mesh:

Year:  2003        PMID: 12839109     DOI: 10.1016/s1081-1206(10)61656-0

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  5 in total

1.  DS-70, a novel and potent α4 integrin antagonist, is an effective treatment for experimental allergic conjunctivitis in guinea pigs.

Authors:  Samantha Deianira Dattoli; Monica Baiula; Rossella De Marco; Andrea Bedini; Michele Anselmi; Luca Gentilucci; Santi Spampinato
Journal:  Br J Pharmacol       Date:  2018-09-17       Impact factor: 8.739

Review 2.  Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis.

Authors:  Leonard Bielory; Kenneth W Lien; Steve Bigelsen
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Ocular allergy in the Asia Pacific region.

Authors:  Constance H Katelaris
Journal:  Asia Pac Allergy       Date:  2011-10-06

4.  Trifuhalol A Suppresses Allergic Inflammation through Dual Inhibition of TAK1 and MK2 Mediated by IgE and IL-33.

Authors:  Sim-Kyu Bong; No-June Park; Sang Heon Lee; Jin Woo Lee; Aaron Taehwan Kim; Xiaoyong Liu; Sang Moo Kim; Min Hye Yang; Yong Kee Kim; Su-Nam Kim
Journal:  Int J Mol Sci       Date:  2022-09-05       Impact factor: 6.208

5.  Allergic conjunctivitis and the most common allergens in Northern Greece.

Authors:  Diamantis Almaliotis; Pavlos Michailopoulos; Dimitrios Gioulekas; Paschalina Giouleka; Despina Papakosta; Thomas Siempis; Vasileios Karampatakis
Journal:  World Allergy Organ J       Date:  2013-07-16       Impact factor: 4.084

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.